Pfizer said it would ask the Food and Drug Administration on Friday to allow emergency use of its coronavirus vaccine.
That would make the company and its German partner, BioNTech, the first coronavirus vaccine developers to submit their shot for review by U.S. regulators. The FDA is is expected to issue a decision within weeks.
The companies said their submission will include safety data on 8,000 people under age 18, including 100 in the 12-15 age range — potentially setting the vaccine up for use by teenagers. Data the companies released this week also showed the shot was 94 percent effective in the elderly, whose immune systems are generally weaker than those of younger adults or children.
Read more at Politico.